Stanford University
Showing 10,901-11,000 of 14,475 Results
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants. -
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
Lea Rosenbohm
Director, Policy & Engagement, Woods Institute
Current Role at StanfordDirector, Policy & Engagement
-
Sin Rosenthal
Finance Manager, Office of Technology Licensing (OTL)
BioSin is responsible for royalty sharing agreements, equity related tasks, billing licensees, aging reports, progress and earned royalty reports, royalty distribution, and special projects that are assigned to her.
-
Maryam Rostami
Professional-NX, Psychiatry and Behavioral Sciences
BioMaryam Rostami is a professional data analyst in the Department of Psychiatry and Behavioral Science at Stanford university, currently working in the area of neuroethics and public health. She got a PhD in cognitive neuroscience and neuroimaging from Tohoku university/Japan that folloed by two years of research in the same area at Stanford university.
-
Charlene Larson Rotandi
Associate Director of Fellowship Education, Pediatrics
Current Role at StanfordAssociate Director of Fellowship Education, Department of Pediatrics
Leads initiatives that support the development, administration, and continuous improvement of the 26 subspecialty programs in the Department of Pediatrics. My work focuses on curriculum development and assessment, program accreditation, faculty and program coordinator development, and enhancing the educational experience for our 130+ trainees. I collaborate closely with program leadership and the Graduate Medical Education office to ensure compliance with accreditation standards while advancing innovative approaches to training, mentorship, and professional development. Through my work, I aim to strengthen our learning community by supporting our educational leaders and fostering a collaborative learning environment that promotes trainee success and well-being. -
Raheleh Roudi
Basic Life Research Scientist, Rad/Pediatric Radiology
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers. -
Alex Rousina-Webb
Research Technical Manager, SLAC National Accelerator Laboratory
Current Role at StanfordAt SLAC National Accelerator Laboratory, I lead the lab-to-market pipeline for SLAC innovations. My role includes collaborating with Stanford University’s tech transfer program, managing DOE technology transfer initiatives like OTT and SBIR/STTR, and handling SLAC’s intellectual property portfolio. I work closely with the Stanford Office of Technology Licensing to drive innovation from discovery to commercialization.
-
Larissa Roux MD PhD
Adjunct Professor, Medicine - Primary Care and Population Health
BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.
-
Jenny Roxas
Associate Director of Belonging, Access, & Career Equity (BACE), BEAM, Stanford Career Education
Current Role at StanfordAssociate Director of Career Coaching and Education - Belonging, Access, & Career Equity (BACE)
-
Anuradha Roy
Casual - Non-Exempt, Anesthesia - Adult Pain Medicine
BioAnuradha (Anu) Roy is the Project Manager for the NCCIH R01 Grant, Single Session Pain Catastrophizing Treatment Efficacy and Mechanisms Trial in Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford Medical School. Originally from the East Coast, she received her BS in Biomedical Engineering from the University of Virginia and her MSc in Public Health in Developing Countries from London School of Hygiene & Tropical Medicine. After years of working abroad in global public health, her research interest transitioned to the public health impact of chronic health conditions - in particular, chronic pain - and understanding the intersection of mind’s impact on health and well-being. For the past three years, on the R01, she has been running day-to-day operations and management of study recruitment, data collection/pre-processing, and reporting. In the near future, she plans to pursue a PhD in Clinical Psychology. In her spare time, Anu enjoys home/exterior design projects, spending time with her partner and dog, creating community, and finding the best food in the San Francisco Bay Area.
-
Sam Rubin
Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioSam Joined OTL in September 2022 as a Licensing Associate on the Life Sciences team. Prior to joining, Sam worked in various business-focused roles in the life science industry. He has experience negotiating and executing services agreements for complex drug development collaborations, as well as technology licensing agreements with industry partners.
-
José D. Rubio-Zepeda
Assistant Director for Inclusion and Belonging, Stanford Doerr School of Sustainability - Dean's Office
Current Role at StanfordAssistant Director for Inclusion and Belonging
-
Uta Ruett
Senior Scientist, SLAC National Accelerator Laboratory
BioUta Ruett is an expert in high-energy x-ray diffraction. Her research is dedicated to developing methods and instrumentation for in situ and operando structural analysis at x-ray user facilities. Her scientific interests cover a wide range of diffraction applications, including solid-state physics, synthesis of new materials, catalysis, and electrochemistry. In recent years, her primary focus has been on the structural analysis of disordered thin films and interfaces.
Uta Ruett received her diploma in Physics from the University of Hamburg, Germany, in 1993, and her Ph.D. in Physics from the same institution in 1996. She began her postdoctoral research at Northern Illinois University before becoming an assistant scientist at Argonne National Laboratory. She then worked at the Max-Planck-Institute for Solid-State Physics in Stuttgart, Germany, before joining DESY in Hamburg, Germany, as a staff scientist and later as a Beamline Manager at PETRA III, DESY, Germany. In 2017, Uta Ruett accepted the position of group leader at the Advanced Photon Source (APS), where she oversaw the development and research program of five high-energy x-ray scattering beamlines. In 2024, she joined SLAC as a senior advisor for future projects at the Stanford Synchrotron Radiation Lightsource (SSRL).
